Bradley S Galer

Title: The Innovative Contributions of Bradley S. Galer

Introduction

Bradley S. Galer is a prominent inventor based in West Chester, PA, known for his significant contributions to medical treatments. With a total of 17 patents to his name, he has made remarkable strides in addressing critical health issues.

Latest Patents

Among his latest patents is a method of treating patients with a mutation in cyclin-dependent kinase-like 5 (CDKL5). This method focuses on treating and preventing symptoms of Rett syndrome (RTT) by administering an effective dose of a 5-HT or sigma-1 receptor agonist, such as fenfluramine. RTT patients are treated at a preferred dose of less than about 1.0 mg/kg/day, with fenfluramine administered in amounts ranging from 0.2 to 0.8 mg/kg/day, up to a maximum of 30 mg/day in a liquid oral dose. Another significant patent involves a method of treating patients infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). This method includes determining the patient's infection status and administering a therapeutically effective dose of fenfluramine.

Career Highlights

Throughout his career, Bradley has worked with notable companies, including Nuvo Research Inc. and Horizon Therapeutics. His work has been instrumental in developing innovative treatments that address pressing health concerns.

Collaborations

Bradley has collaborated with esteemed colleagues, including Jagat Singh and Edward Thomas Kisak, contributing to the advancement of medical research and treatment methodologies.

Conclusion

Bradley S. Galer exemplifies the spirit of innovation in the medical field through his patents and collaborations. His work continues to impact the lives of patients facing serious health challenges.